TONELLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 13.884
AS - Asia 8.066
EU - Europa 7.322
SA - Sud America 1.309
AF - Africa 225
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 8
Totale 30.886
Nazione #
US - Stati Uniti d'America 13.514
IT - Italia 2.875
SG - Singapore 2.706
CN - Cina 1.961
GB - Regno Unito 1.034
VN - Vietnam 997
BR - Brasile 950
HK - Hong Kong 858
DE - Germania 723
SE - Svezia 627
RU - Federazione Russa 363
FI - Finlandia 337
FR - Francia 329
KR - Corea 248
IN - India 229
ID - Indonesia 216
CA - Canada 211
NL - Olanda 177
AR - Argentina 138
TR - Turchia 138
UA - Ucraina 125
JP - Giappone 123
MX - Messico 120
BD - Bangladesh 103
BG - Bulgaria 87
ES - Italia 83
IE - Irlanda 80
PL - Polonia 72
IQ - Iraq 71
ZA - Sudafrica 67
AU - Australia 65
CO - Colombia 65
PK - Pakistan 61
LT - Lituania 54
AT - Austria 48
RO - Romania 48
AE - Emirati Arabi Uniti 44
EC - Ecuador 42
BE - Belgio 41
CL - Cile 41
CH - Svizzera 32
MA - Marocco 30
TW - Taiwan 30
CZ - Repubblica Ceca 28
MY - Malesia 27
EG - Egitto 26
VE - Venezuela 26
JO - Giordania 25
TH - Thailandia 25
UZ - Uzbekistan 23
DZ - Algeria 21
SA - Arabia Saudita 21
PH - Filippine 20
SI - Slovenia 20
IR - Iran 19
KE - Kenya 19
PY - Paraguay 19
GR - Grecia 16
NP - Nepal 16
TN - Tunisia 16
PE - Perù 15
AZ - Azerbaigian 14
DK - Danimarca 14
HU - Ungheria 12
IL - Israele 12
CR - Costa Rica 11
KZ - Kazakistan 11
NO - Norvegia 11
PT - Portogallo 11
SN - Senegal 11
DO - Repubblica Dominicana 10
HR - Croazia 9
MD - Moldavia 9
OM - Oman 9
RS - Serbia 9
EE - Estonia 8
AL - Albania 7
GE - Georgia 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
BH - Bahrain 6
BY - Bielorussia 6
GA - Gabon 6
KG - Kirghizistan 6
LB - Libano 6
PA - Panama 6
BO - Bolivia 5
ET - Etiopia 5
LI - Liechtenstein 5
MK - Macedonia 5
PS - Palestinian Territory 5
QA - Qatar 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LK - Sri Lanka 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
CG - Congo 3
CY - Cipro 3
Totale 30.834
Città #
Singapore 1.759
Ashburn 1.653
Santa Clara 1.443
Fairfield 1.279
Chandler 840
Hong Kong 831
San Jose 613
Woodbridge 595
Hefei 580
Houston 508
Seattle 467
Cambridge 407
Southend 399
Beijing 373
Wilmington 371
London 360
Nyköping 349
Council Bluffs 344
Ho Chi Minh City 322
Ann Arbor 307
New York 274
Modena 257
Los Angeles 256
Milan 255
Helsinki 242
Seoul 228
Hanoi 224
Chicago 220
San Diego 207
Jakarta 188
Bologna 182
The Dalles 172
Dearborn 160
Munich 158
Rome 152
Jacksonville 123
Moscow 111
Lauterbourg 104
Shanghai 104
Dallas 101
Tokyo 98
São Paulo 96
Princeton 94
Sofia 84
Orem 78
Redwood City 68
Buffalo 67
Toronto 66
Dublin 62
Grafing 62
Frankfurt am Main 60
Salt Lake City 60
Parma 57
Warsaw 54
Mexico City 51
Mumbai 46
Nuremberg 46
Bremen 45
Chennai 45
Elk Grove Village 44
Da Nang 43
Eugene 43
Boardman 42
Lappeenranta 42
Naples 41
Poplar 41
Atlanta 40
Haiphong 39
Montreal 39
North York 37
Turin 37
Verona 37
Florence 36
Sydney 35
Denver 34
Reggio Emilia 34
Hangzhou 33
Johannesburg 33
Rio de Janeiro 33
Ankara 32
Brussels 32
Turku 32
Guangzhou 31
Phoenix 31
Kent 30
Baghdad 29
Izmir 28
Stockholm 28
Amsterdam 27
Des Moines 27
Hillsboro 27
Redondo Beach 27
Tampa 27
Boston 26
Brooklyn 26
Dong Ket 26
Paris 26
Lahore 25
Miami 25
Fremont 24
Totale 20.106
Nome #
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 446
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 425
Insufficienza respiratoria acuta e cronica (cap.21). 385
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 371
Acute severe asthma: management and treatment. 368
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 364
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 363
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 362
An uncommon cause of hemoptysis: aortobronchial fistula. 353
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 345
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 345
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 340
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 332
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 330
An uncommon cause of pneumonia: The golden diagnosis 328
When Acute Respiratory Distress Syndrome is not ARDS 328
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 328
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 326
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 325
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 323
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 319
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 316
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 315
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 311
Hypokalemia in Patients with COVID-19 307
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 307
Breakthroughs in internal and respiratory medicine 301
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 300
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 300
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 299
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 298
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 293
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 287
Novel drug targets for idiopathic pulmonary fibrosis 285
Peritoneal dialysis in the time of coronavirus disease 2019 284
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 281
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 280
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 280
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 279
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 278
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 277
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 272
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 270
Looking for a Chronic Care Model in COPD patients 267
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 264
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 264
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 263
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 262
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 259
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 259
The encaged lung: rapidly progressive idiopathic pleurisy. 255
Atypical diagnosis for typical lung carcinoid 246
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 245
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 245
Never Give Up: lesson learned from a severe COVID-19 patient. 244
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 244
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia. 240
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 239
STenting veRsus balloOn dilatation in patients with tracheal BEnign stenosis – the STROBE trial. 238
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 236
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 236
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 234
Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate order. 231
Biological effects of COVID-19 on lung cancer: can we drive our decisions? 229
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 226
Janus-faced amiodarone-induced pneumopathy 226
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 224
Proprietà meccaniche e comportamento elastico del polmone affetto da fibrosi con pattern "polmonite interstiziale tipica" in corso di ventilazione meccanica: sviluppo e significato clinico della teoria del polmone "squishy ball" 224
Response Letter to Tuffet S, et al. and to Michard F, et al. 222
The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis 221
Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma. 219
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 219
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 218
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 217
Impaired function in the complex patient with COPD: a matter to be considered 215
An Italian sacrifice to COVID-19 epidemic. 213
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 212
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation 208
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 208
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 206
Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft 206
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 203
Unusual effectiveness of systemic steroids in Whipple disease. 203
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases. 201
Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia (BMC Pulmonary Medicine, (2021), 21, 1, (307), 10.1186/s12890-021-01653-w) 200
Physiological effects of lung protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study. 196
Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia 196
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 193
Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing 192
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 192
Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula 191
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 191
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 188
Extensive tracheal injuries: a reasoned multi-step approach to guarantee mechanical ventilatory support developed during COVID-19 pandemic. 186
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 185
Accuracy of nasal pressure swing to predict failure of high flow nasal oxygen in patients with acute hypoxemic respiratory failure 184
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 183
Ventilazione meccanica domiciliare (cap.26) 182
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 177
Totale 26.658
Categoria #
all - tutte 124.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021773 0 0 0 0 0 0 0 0 0 297 265 211
2021/20222.942 279 167 152 122 160 201 195 175 486 220 459 326
2022/20232.874 346 363 250 281 279 361 94 274 334 57 124 111
2023/20242.367 68 110 182 223 330 243 278 242 102 120 189 280
2024/20256.252 178 123 143 455 1.077 919 515 410 684 318 576 854
2025/202611.429 971 566 999 1.576 1.848 778 1.561 683 1.269 1.178 0 0
Totale 31.233